Anti-SARS-CoV-2 Antibodies in Urine of Individuals Vaccinated with Janssen AD26.COV2.S COVID-19 Vaccine
Pathogens · 2025
DOI: 10.3390/pathogens14080827 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathogens, 2025. Verfasst von Marina F N Melo und 14 weiteren Autor:innen. Beteiligte Einrichtung: Programa de Pós-Graduação em Ciências da Saúde, Infectologia e Medicina Tropical, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo H…. Hauptthemen laut MEDLINE: Antibodies, Viral, SARS-CoV-2, COVID-19 Vaccines, COVID-19. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de Minas Gerais, National Council for Scientific and Technological Development, Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq).
Abstract (Originalsprache)
Urine-based immunoassay is a non-invasive method with demonstrated utility in detecting anti-SARS-CoV-2 antibodies in unvaccinated patients with COVID-19. To evaluate urine’s potential for serological surveys in a real-world setting, SARS-CoV-2 serology was performed on urine samples from vaccinated individuals, both with and without prior confirmed COVID-19. (1)
Methods
An in-house indirect ELISA was used to measure antibodies against recombinant spike (S) and nucleocapsid (N) proteins of SARS-CoV-2 in urine and paired serum from 149 individuals vaccinated with Janssen AD26.COV2.S, an S protein-based COVID-19 vaccine. (2)
Results
Anti-S and anti-N levels were higher in the urine and serum of participants with confirmed prior COVID-19 compared to those without prior infection. Urinary anti-S effectively distinguished vaccinated individuals with (AUC = 0.96) and without (AUC = 0.88) prior infection from negative controls (non-vaccinated, non-previously infected individuals) (p < 0.0001). Among vaccinated participants, urinary anti-S and anti-N identified prior infection, with AUC values of 0.73 (p < 0.0001) and 0.60 (p = 0.03), respectively, being recorded. (3)
Conclusions
Findings indicate that urinary anti-SARS-CoV-2 antibodies reflect AD26.COV2.S vaccination and previous COVID-19. To further advance the methodology, studies with larger sample sizes and a greater diversity of COVID-19 vaccines are required.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Programa de Pós-Graduação em Ciências da Saúde, Infectologia e Medicina Tropical, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte 30.130-100, Minas Gerais, Brazil.
- Programa de Pós-Graduação em Ciências da Saúde, Faculdade de Ciências Médicas de Minas Gerais, Belo Horizonte 30.130-110, Minas Gerais, Brazil.
- Laboratório de Virologia Básica e Aplicada, Departamento de Microbiologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte 31.270-901, Minas Gerais, Brazil.
- Departamento de Pediatria, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte 30.130-100, Minas Gerais, Brazil.
ORCID-Profile: Rômulo C D Lira, Fernanda F Ramos, Flávio G da Fonseca, Vandack Nobre, Flavia G F Ferreira, Jorge Pinto, Eduardo A F Coelho, Fernanda Ludolf
Förderung
- Fundação de Amparo à Pesquisa do Estado de Minas Gerais
- National Council for Scientific and Technological Development
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
Zitieren
APA
Melo, M. F. N., Lira, R. C. D., Câmara, R. S. B., Pereira, I. A. G., Ramos, F. F., Costa, C. S. F., Amorim, L. F., Teixeira, Q. D., da Fonseca, F. G., Nobre, V., Ferreira, F. G. F., Pinto, J., Coelho, E. A. F., Ludolf, F., & Caporali, J. F. M. (2025). Anti-SARS-CoV-2 Antibodies in Urine of Individuals Vaccinated with Janssen AD26.COV2.S COVID-19 Vaccine. Pathogens. https://doi.org/10.3390/pathogens14080827
Vancouver
Melo MFN, Lira RCD, Câmara RSB, Pereira IAG, Ramos FF, Costa CSF, et al. Anti-SARS-CoV-2 Antibodies in Urine of Individuals Vaccinated with Janssen AD26.COV2.S COVID-19 Vaccine. Pathogens. 2025. doi:10.3390/pathogens14080827
BibTeX
@article{Melo2025,
author = {Melo, Marina F N and Lira, Rômulo C D and Câmara, Raquel S B and Pereira, Isabela A G and Ramos, Fernanda F and Costa, Carolina S F and Amorim, Laura F and Teixeira, Quezia D and da Fonseca, Flávio G and Nobre, Vandack and Ferreira, Flavia G F and Pinto, Jorge and Coelho, Eduardo A F and Ludolf, Fernanda and Caporali, Júlia F M},
title = {Anti-SARS-CoV-2 Antibodies in Urine of Individuals Vaccinated with Janssen AD26.COV2.S COVID-19 Vaccine},
journal = {Pathogens},
year = {2025},
doi = {10.3390/pathogens14080827}
}
EUVIMED